Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
ChemMedChem ; 17(22): e202200421, 2022 11 18.
Artigo em Inglês | MEDLINE | ID: mdl-36106757

RESUMO

A series of pyrrolo[2,3-d]pyrimidines were designed in silico as potential bumped kinase inhibitors targeting P. falciparum calcium dependent protein kinase 4 (PfCDPK4), with the potential to inhibit PfCDPK1 based on earlier studies of the two kinases. A small series of these compounds were prepared and assessed for inhibitory activity against PfCDPK4 and PfCDPK1 in vitro. Four of the compounds displayed promising inhibitory activity against either PfCDPK4 (IC50 =0.210-0.530 µM), or PfCDPK1 (IC50 =0.589 µM). These data will enable optimisation of the molecular model to better predict inhibitory activity against PfCDPK4.


Assuntos
Antimaláricos , Plasmodium falciparum , Inibidores de Proteínas Quinases , Aminas , Plasmodium falciparum/efeitos dos fármacos , Plasmodium falciparum/enzimologia , Inibidores de Proteínas Quinases/farmacologia , Proteínas Quinases/metabolismo , Pirimidinas/farmacologia , Relação Estrutura-Atividade , Antimaláricos/farmacologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA